SCHEMBL25600545

SCHEMBL25600545

CCC1(CC)c2cc(-c3ccccc3)ccc2-c2c1c1c(c3cc(OC)ccc23)OC(c2ccc(OC)cc2)(c2ccc(N3CCOCC3)cc2)C=C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
TSHR P16473 2/20 0.34
TP53 P04637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
AKT1 P31749 1/20 0.34
MMP2 P08253 2/20 0.33
MMP3 P08254 2/20 0.33
MMP13 P45452 2/20 0.33
MMP1 P03956 1/20 0.33
PTGDR Q13258 1/20 0.33
HTR1A P08908 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RAB9A P51151 2/20 0.33
ADAM17 P78536 1/20 0.32
PTPN1 P18031 1/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25600548 0.99 ALDH1A1 (0.34) PRKDCALDH1A1KDM4ETSHRTP53
SCHEMBL25600428 0.98 PRKDC (0.35) PRKDCALDH1A1KDM4ETSHRTP53
SCHEMBL25607263 0.97 AKT1 (0.35) PRKDCALDH1A1KDM4ETSHRTP53
SCHEMBL25600769 0.96 PRKDC (0.38) PRKDCALDH1A1KDM4ETDP1AKT1
SCHEMBL26627754 0.94 NTSR1 (0.35) PRKDCALDH1A1KDM4EAKT1MMP2
SCHEMBL25600543 0.93 PRKDC (0.33) PRKDCALDH1A1KDM4ETSHRTP53
SCHEMBL25600547 0.93 PRKDC (0.32) PRKDCALDH1A1KDM4ETSHRTP53
SCHEMBL25600424 0.93 RAB9A (0.36) PRKDCALDH1A1KDM4ETSHRHSD17B10
SCHEMBL25600429 0.93 KDM4E (0.35) PRKDCALDH1A1KDM4ETDP1RAB9A
SCHEMBL25600425 0.92 ADAM17 (0.36) PRKDCALDH1A1KDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
EP-4198102-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 PRKDC 4850/4885ALDH1A1 1091/4885KDM4E 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.